A Physician Attack on the FDA - Will the Supreme Court Reduce Access to Mifepristone?

N Engl J Med. 2024 Feb 8;390(6):563-567. doi: 10.1056/NEJMms2312012. Epub 2024 Jan 24.
No abstract available

MeSH terms

  • Abortifacient Agents* / supply & distribution
  • Abortifacient Agents* / therapeutic use
  • Abortion, Induced* / legislation & jurisprudence
  • Abortion, Induced* / methods
  • Female
  • Humans
  • Mifepristone* / supply & distribution
  • Mifepristone* / therapeutic use
  • Pregnancy
  • Supreme Court Decisions*
  • United States
  • United States Food and Drug Administration* / legislation & jurisprudence

Substances

  • Mifepristone
  • Abortifacient Agents